HONG KONG – Chinese pharmaceutical companies in areas around the capital of Beijing are expecting to take a hit to their bottom lines for an unusual reason: pollution. Drug manufacturers in the province that neighbors Beijing were ordered to "temporarily" halt operations to address severe smog in the capital. Read More

HONG KONG – Singapore is becoming a hotbed for stem cell research. And a recent breakthrough involving a stem cell treatment for diabetic wounds, developed by Cellresearch Corp. Pte. Ltd., could further cement the nation's reputation as a leader in biomedical innovation. Read More

DOHA, Qatar – Advances in genomics have made mapping the genome of individuals both cheap and easy, but those same advances are leading to questions about the suitability of long-held practices of data-based research and a host of concerns of how to develop ethical standards. Read More

PERTH, Australia – Following its IPO in August, Melbourne-based Adalta Pty Ltd. inked two deals this month, and is now moving to the clinic with its human version of the shark antibody platform, the i-body. Read More

Chugai Pharmaceutical Co. Ltd., of Tokyo, and Berlin-Chemie Menarini, of Florence, Italy, a company of the Menarini Group, have entered into a global license agreement for PA799, class I PI3K inhibitor. Read More